HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas J Balkin Selected Research

Caffeine (No Doz)

1/20222B-Alert Web 2.0, an Open-Access Tool for Predicting Alertness and Optimizing the Benefits of Caffeine: Utility Study.
9/2020TNFα G308A genotype, resilience to sleep deprivation, and the effect of caffeine on psychomotor vigilance performance in a randomized, double-blind, placebo-controlled, crossover study.
12/2017Limited Efficacy of Caffeine and Recovery Costs During and Following 5 Days of Chronic Sleep Restriction.
10/2014Dose-dependent model of caffeine effects on human vigilance during total sleep deprivation.
10/2014Caffeine improves the efficiency of planning and sequencing abilities during sleep deprivation.
2/2013A biomathematical model of the restoring effects of caffeine on cognitive performance during sleep deprivation.
2/2012Gambling when sleep deprived: don't bet on stimulants.
9/2011Caffeine protects against increased risk-taking propensity during severe sleep deprivation.
2/2009Sustaining executive functions during sleep deprivation: A comparison of caffeine, dextroamphetamine, and modafinil.
1/2009Modeling fatigue over sleep deprivation, circadian rhythm, and caffeine with a minimal performance inhibitor model.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas J Balkin Research Topics

Disease

22Sleep Deprivation
01/2022 - 01/2002
6Fatigue
01/2022 - 06/2004
5Sleepiness
12/2017 - 06/2006
1Cognitive Dysfunction
01/2022
1Pain (Aches)
01/2019
1Gambling (Pathological Gambling)
02/2012
1Obstructive Sleep Apnea
12/2010
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
10/2007
1Dementia (Dementias)
10/2007

Drug/Important Bio-Agent (IBA)

19Caffeine (No Doz)FDA LinkGeneric
01/2022 - 01/2002
8Modafinil (Provigil)FDA Link
02/2012 - 01/2002
6Dextroamphetamine (Dexedrine)FDA LinkGeneric
02/2012 - 09/2005
2Uridine Monophosphate (UMP)IBA
01/2016 - 06/2015
2Pharmaceutical PreparationsIBA
09/2011 - 06/2004
1Pain-FreeIBA
01/2019
1Indicators and Reagents (Reagents)IBA
01/2019
1Biomarkers (Surrogate Marker)IBA
10/2011
1Complement System Proteins (Complement)IBA
03/2011
1CX717IBA
10/2007
1Dihydrotachysterol (AT 10)IBA
02/2005

Therapy/Procedure

1Precision Medicine
09/2019
1Continuous Positive Airway Pressure
12/2010
1Therapeutics
12/2010
1Behavior Control
09/2008